Genetic influence on the development of renoprival hypertension in parabiotic rats. Evidence that a humoral hypertensinogenic factor is produced in kidney tissue of hypertension-prone rats.
Knudsen KD, Iwai J, Heine M, Leitl G, Dahl LK.
J Exp Med. 1969 Dec 1;130(6):1353-65. doi: 10.1084/jem.130.6.1353.
Renoprival hypertension and antirenin.
KOLFF WJ, PAGE IH.
Am J Physiol. 1955 Jun;181(3):575-9. doi: 10.1152/ajplegacy.1955.181.3.575.
SOME FACTORS IN RENAL AND RENOPRIVAL HYPERTENSION.
DUSTAN HP, PAGE IH.
J Lab Clin Med. 1964 Dec;64:948-59.
Haemodynamic and other studies in the renoprival hypertensive rat.
Ledingham JM, Pelling D.
J Physiol. 1970 Sep;210(1):233-53. doi: 10.1113/jphysiol.1970.sp009206.
The role of the kidney in hypertension.
Ledingham JM, Floyer MA, Goodwin FJ, Lucas J, Mourant AJ, Slack B.
Contrib Nephrol. 1977;8:37-43. doi: 10.1159/000400612.
On the pathogenesis of the renoprival hypertension in dogs.
Giovannetti S, Bigalli A, Balestri PL.
Experientia. 1965 May 15;21(5):288-9. doi: 10.1007/BF02297034.
Soluble guanylate cyclase stimulators and activators as potential antihypertensive drugs.
Tawa M, Nakagawa K, Ohkita M.
Hypertens Res. 2025 Apr;48(4):1458-1470. doi: 10.1038/s41440-025-02110-5. Epub 2025 Jan 20.
Vascular reactivity in experimental renal and renoprival hypertension.
MCQUEEN EG.
Clin Sci. 1956 Nov;15(4):523-32.
[RENOPRIVAL HYPERTENSION AND RENAL HYPERTENSION].
OSHIMA K, SUGINO N.
Naika. 1963 Dec;12:1011-6.
Effect of DCA on development of renoprival hypertension.
LANGFORD HG, SNAVELY JR.
Am J Physiol. 1959 Feb;196(2):449-50. doi: 10.1152/ajplegacy.1959.196.2.449.
